Picture of Dermapharm Holding SE logo

DMP — Dermapharm Holding SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Dermapharm H1 Adjusted EBITDA EUR 168 Million

Aug 16 (Reuters) - Dermapharm H1 EBITDA EUR 137 million.
* H1 EBITDA margin 23.5%
* H1 adjusted EBITDA margin 28.9%
* H1 revenue EUR 582 million

Recent news on Dermapharm Holding SE

See all news